30 November
SmartPharm Therapeutics, a subsidiary of Sorrento Therapeutics, announced that it had been awarded a contract worth up to $34m by the Defence Advanced Research Projects Agency (DARPA) and the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) to create a rapid countermeasure against the Covid-19 disease. The fund is to be utilised by SmartPharm for its phase 2 clinical studies of Gene MAb that enable protection from and treatment of the SARS-CoV-2 virus.
Go deeper with GlobalData
According to local health authorities, a South Korean army artillery school has reported an outbreak of coronavirus, with 16 soldiers undergoing training or stationed at the Sangmudae Artillery School in Jangseong having tested positive for the Covid-19.
Ukrainian Ambassador to Germany, Andriy Melnyk, announced that Germany would be providing 20 Life Base III artificial lung ventilation devices to the Ukrainian military. Approximately 12,978 new coronavirus cases, including children and medics, have been reported over the past 24 hours by Ukrainian officials.
According to the Austria Press Agency, the Austrian defence minister Klaudia Tanner has tested positive for the coronavirus, becoming the second Cabinet member to be infected by the virus. The agency reported that she was doing well and will be continuing to work from home. She was already in quarantine after meeting with an infected individual.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
